Articles

A single, once-daily injection to lower both fasting and postprandial blood glucose

Are clinicians intensifying treatment before it is too late?

Initiation of glucagon like peptide-1 agonists may increase risk of gallbladder or bile duct disease and cholecystectomy; no increased risk associated with DPP-4 inhibitor therapy.

Is A1c better than an Oral Glucose Tolerance Test in diabetes management?

New research shows varied individual responses to GI values may be confusing for patients

Early studies of novel agent LGD-6972 show potential as an adjunct therapy to diet and exercise for patients with type 2 diabetes.

Why are people inactive, especially when they have diabetes and know how much physical activity could benefit them? If they’re older, overweight or obese, arthritic, or dealing with other physical or joint limitations, they may not feel capable of walking for exercise, and they may not have easy access to other types of activities. This may be particularly true of adults with nerve damage in their feet or arthritic knees for whom walking for exercise is just not feasible. Enter the Corratec Life Bike, particularly designed with adults with diabetes in mind.

A1C reductions seen in therapy combined with metformin

Can glycated albumin provide better positive predictive value than A1c in incidence of diabetic nephropathy?

Canagliflozin can decrease blood sugar and provide control, but what other metabolic effects can it provide?